Exatecan
- Level
- Commodity
- Parent
- 51111600
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51111638This classification denotes a camptothecin analogue with the molecular formula C24H22FN3O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier OC71PP0F89, chemically known as 10h,13h-benzo(de)pyrano(3,4:6,7)indolizino(1,2-b)quinoline-10,13-dione, 1-amino-9-ethyl-5-fluoro-1,2,3,9,12,15-hexahydro-9-hydroxy-4-methyl-, (1s-trans)- but generally known as exatecan, which bears US NIH Compound Identifier 151115. The term EXATECAN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 14, No. 1, 2000, List 43). Most nations schedule exatecan under HS 29399900 and SITC 54149. As of Q4 2014, EXATECAN remains the US FDA Preferred Term for this commodity. Exatecan bears US NLM identifiers UMLS ID C0965941 and NCI Concept Code C66720. SMILES: CCC1(C2=C(COC1=O)C(=O)N3CC4=C5C(CCC6=C5C(=CC(=C6C)F)N=C4C3=C2)N)O.
Same parent
Under 51111600 · 55Activities that produce or sell this
KBLI · 8Inherited from family 51110000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.